PARTNERS
Antaros Medical - Expertise Partner
Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems
to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal and metabolic diseases and oncology.
Curi Bio - Innovation Partner
Curi Bio unlocks novel workflows and critical human data to inform R&D decisionmaking. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/MLenabled insights, Curi Bio merges functional and analytical assessments for assessing drug safety, efficacy, and potency.
Physiogenex - Innovation Partner
Physiogenex is a preclinical CRO providing original and benchmarked animal models of obesity/type 2 diabetes and related co-morbidities: MASH, dyslipidemia, inflammation, diabetic nephropathy, HFpEF and atherosclerosis. For >20 years, we have been evaluating the efficacy of our clients’ drugs using goldstandard experiments in our validated preclinical models. Our customers benefitfrom our experience in drug development and expertise in metabolic diseases, as demonstrated by our numerous co-publications with our industrial partners. Our expertise – your success.